Showing 1,961 - 1,980 results of 100,777 for search '(( 12 nn decrease ) OR ( 5 ((((we decrease) OR (a decrease))) OR (teer decrease)) ))', query time: 1.46s Refine Results
  1. 1961

    Pre-treatment with GnRHa or <i>ulipristal acetate</i> prior to laparoscopic and laparotomic myomectomy: A systematic review and meta-analysis by Inge de Milliano (4515127)

    Published 2017
    “…Pre-treatment with GnRHa before laparoscopic myomectomies also shows a reduction in intra-operative blood loss by 23.03ml (95% CI -40.79 to -5.27) and in the frequency of blood transfusions (OR 0.17, 95% CI 0.05 to 0.55) compared to no pre-treatment.…”
  2. 1962

    Effects of anchor-away depletion of Esa1, Gcn5 and Esa1/Gcn5 together. by Xue Cheng (6400607)

    Published 2021
    “…Esa1 depletion shows rapid loss of H4ac (penta) while Gcn5 depletion shows a decrease of H3ac, most notably H3K27ac. …”
  3. 1963
  4. 1964
  5. 1965
  6. 1966
  7. 1967

    Semi-log plot of the FIFA countries ranked by their decreasing “order of importance” through the FIFA coefficient; the best 5-parameter function, Eq (5), is shown. by Marcel Ausloos (748325)

    Published 2016
    “…<p>Semi-log plot of the FIFA countries ranked by their decreasing “order of importance” through the FIFA coefficient; the best 5-parameter function, <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0166011#pone.0166011.e005" target="_blank">Eq (5)</a>, is shown.…”
  8. 1968
  9. 1969

    AICD transgenic mice show decreased cell proliferation in the SGZ of hippocampus. by Kaushik Ghosal (244754)

    Published 2010
    “…(<b>A–B</b>) At 1.5 mo there was no statistically significant difference in the number of BrdU-labeled cells between wild-type and FeCγ25 mice, quantified in (<b>B</b>). …”
  10. 1970
  11. 1971
  12. 1972

    Knockdown of NRP1 increases while knockdown of NRP2 decreases formation of Schwann cell clusters. by Kasper C. D. Roet (444802)

    Published 2014
    “…<p>(A–C) Representative SC clusters when co-cultured with MCs for 5 days after a transfection with siGlo, siNRP1 pool or siNRP2 pool respectively. …”
  13. 1973

    Identification of a Hydroxypyrimidinone Compound (<b>21</b>) as a Potent APJ Receptor Agonist for the Potential Treatment of Heart Failure by Wei Meng (505670)

    Published 2021
    “…Due to the increased polarity at C2, the permeability for these compounds decreased. Further adjustment of the polarity by replacing the N1 2,6-dimethoxyphenyl group with a 2,6-diethylphenyl group and reoptimization for the potency of the C5 pyrroloamides resulted in potent compounds with improved permeability. …”
  14. 1974

    Identification of a Hydroxypyrimidinone Compound (<b>21</b>) as a Potent APJ Receptor Agonist for the Potential Treatment of Heart Failure by Wei Meng (505670)

    Published 2021
    “…Due to the increased polarity at C2, the permeability for these compounds decreased. Further adjustment of the polarity by replacing the N1 2,6-dimethoxyphenyl group with a 2,6-diethylphenyl group and reoptimization for the potency of the C5 pyrroloamides resulted in potent compounds with improved permeability. …”
  15. 1975

    Identification of a Hydroxypyrimidinone Compound (<b>21</b>) as a Potent APJ Receptor Agonist for the Potential Treatment of Heart Failure by Wei Meng (505670)

    Published 2021
    “…Due to the increased polarity at C2, the permeability for these compounds decreased. Further adjustment of the polarity by replacing the N1 2,6-dimethoxyphenyl group with a 2,6-diethylphenyl group and reoptimization for the potency of the C5 pyrroloamides resulted in potent compounds with improved permeability. …”
  16. 1976
  17. 1977
  18. 1978
  19. 1979
  20. 1980